Skip to main content

Marès Pagès, Roso

Institutions of which they are part

Research technician
Molecular Medical Imaging
Vall Hebron Institut de Recerca

Marès Pagès, Roso

Institutions of which they are part

Research technician
Molecular Medical Imaging
Vall Hebron Institut de Recerca

Projects

Grups de recerca en Imatge Mèdica Molecular

IP: José Raul Herance Camacho
Collaborators: Joan Castell Conesa, Amparo García Burillo, Manuel Escobar Amores, Gemma Cuberas Borros, Santiago Aguade Bruix, Roso Marès Pagès, Marc Simo Perdigo, Carles Lorenzo Bosquet, Maria Nazarena Pizzi
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 10000
Reference: 2017SGR1303
Duration: 01/01/2017 - 30/09/2021

nTRACK: Multimodal nanoparticles for structural and functional tracking of stem cell therapy on muscle regeneration..

IP: José Raul Herance Camacho
Collaborators: Ana Lain Fernandez, Vicenç Martínez Ibáñez, Laura Vidal Fornells, Carlos Giné Prades, Roso Marès Pagès, Carolina Aparicio Gomez, Queralt Martin Saladich, Julia Baguña Torres, Mario Marotta Baleriola
Funding agency: EUROPEAN COMMISSION
Funding: 1063437.5
Reference: NTRACK_H2020NMBP2017
Duration: 01/10/2017 - 31/03/2022

Nanomedicine and type II diabetes: Pathophysiological and clinical implications.

IP: José Raul Herance Camacho
Collaborators: Roso Marès Pagès
Funding agency: Instituto de Salud Carlos III
Funding: 86313.21
Reference: CP13/00252
Duration: 01/01/2014 - 30/06/2018

Nuevas estrategias terapéuticas para el cáncer de mama: uso de inhibidores de las MNKs y caracterización de nuevos factores que confieren resistencia al estrés celular.

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Maria Rosa Somoza Lopez de Haro, Jordi Temprana Salvador, Roso Marès Pagès, Teresa Moline Marimon, Josep Castellví Vives, Maria Teresa Salcedo Allende, Marta Sese Faustino
Funding agency: Instituto de Salud Carlos III
Funding: 272552.5
Reference: PI14/01320
Duration: 01/01/2015 - 31/03/2018

Related news

The event, organized by Vall d'Hebron and Eurecat, has brought together health professionals and researchers in clinically applied AI to improve the medical care of patients.

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

Phase IV AI is included in the Horizon Europe programme, lasts 3 years and prioritises data security and privacy compliance.

Related professionals

Alejandro  Henao  Paez

Alejandro Henao Paez

Physiology and Pathophysiology of the Digestive Tract
Read more
Amira Idrizovic

Amira Idrizovic

Predoctoral researcher
Childhood Cancer and Blood Disorders
Read more
Cristina Gamez Cenzano

Cristina Gamez Cenzano

Senior researcher
Molecular Medical Imaging
Read more
Camille Guillard Sirieix

Camille Guillard Sirieix

Research technician
Neurodegenerative Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.